OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitotic checkpoint defects: en route to cancer and drug resistance
Sinjini Sarkar, Pranab Kumar Sahoo, Sutapa Mahata, et al.
Chromosome Research (2021) Vol. 29, Iss. 2, pp. 131-144
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Cell cycle control in cancer
Helen K. Matthews, Cosetta Bertoli, Robertus A.M. de Bruin
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 74-88
Open Access | Times Cited: 981

The two sides of chromosomal instability: drivers and brakes in cancer
Rendy Hosea, Sharon Hillary, S. Hassan R. Naqvi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 43

A common signature of cellular senescence; does it exist?
Ewa Sikora, Anna Bielak-Żmijewska, Grażyna Mosieniak
Ageing Research Reviews (2021) Vol. 71, pp. 101458-101458
Closed Access | Times Cited: 84

SOX2 function in cancers: Association with growth, invasion, stemness and therapy response
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113860-113860
Closed Access | Times Cited: 41

Controllability and analysis of sustainable approach for cancer treatment with chemotherapy by using the fractional operator
Muhammad Farman, Maryam Batool, Kottakkaran Sooppy Nisar, et al.
Results in Physics (2023) Vol. 51, pp. 106630-106630
Open Access | Times Cited: 27

Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer
Huicong Zhang, yuhao li, Huixia Lu
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6

Existence, uniqueness and synchronization of a fractional tumor growth model in discrete time with numerical results
Jehad Alzabut, R. Dhineshbabu, A‎. George Maria Selvam, et al.
Results in Physics (2023) Vol. 54, pp. 107030-107030
Open Access | Times Cited: 16

Anti-cancer drug molecules targeting cancer cell cycle and proliferation
Debarun Patra, Kumari Bhavya, Palla Ramprasad, et al.
Advances in protein chemistry and structural biology (2023), pp. 343-395
Closed Access | Times Cited: 13

Adrenal Cortical Carcinoma

American Registry of PathologyArlington, Virginia eBooks (2024), pp. 131-183
Closed Access | Times Cited: 4

Investigating Cisplatin Resistance in Squamous Cervical Cancer: Proteomic Insights into DNA Repair Pathways and Omics-Based Drug Repurposing
Amrita Mukherjee, S. Manna, Avinash Singh, et al.
Journal of Proteome Research (2025)
Closed Access

Mathematical Modeling and Analysis of Tumor Chemotherapy
Ge Song, Guizhen Liang, Tianhai Tian, et al.
Symmetry (2022) Vol. 14, Iss. 4, pp. 704-704
Open Access | Times Cited: 11

BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer
Shunan Wang, Xinyu Liu, Meng Yang, et al.
Disease Markers (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 11

The role of Vps4 in cancer development
Li Huang, Shi Zhan, Yu Pan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5

Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma
Wei Dong, Daqiang Sun, Rafael Sirera, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 7, pp. 1517-1538
Open Access | Times Cited: 5

N-acylhydrazone derivative modulates cell cycle regulators promoting mitosis arrest and apoptosis in estrogen positive MCF-7 breast cancer cells
Melissa Lúcia Melo, Rafael Hinojal Fonseca, Fernanda P. Pauli, et al.
Toxicology in Vitro (2023) Vol. 93, pp. 105686-105686
Closed Access | Times Cited: 4

Norcantharidin in cancer therapy – a new approach to overcoming therapeutic resistance: A review
Beilei Zeng, Xulan Chen, Lijuan Zhang, et al.
Medicine (2024) Vol. 103, Iss. 9, pp. e37394-e37394
Open Access | Times Cited: 1

Sorcin: mechanisms of action in cancer hallmarks, drug resistance and opportunities in therapeutics
Sushmita Ghosh, Arpana Sharma, Rajeev Kumar, et al.
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 1

Unveiling inter-embryo variability in spindle length over time: Towards quantitative phenotype analysis
Yann Le Cunff, Laurent Chesneau, Sylvain Pastezeur, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 9, pp. e1012330-e1012330
Open Access | Times Cited: 1

Targeting CDK2 to combat drug resistance in cancer therapy
Sara Kasirzadeh, Jimma Likisa Lenjisa, Shudong Wang
Future Oncology (2024), pp. 1-17
Closed Access | Times Cited: 1

Editorial: Current understanding of genomic and chromosomal instabilities in solid malignancies
Pavel Vodiĉka, Michal Kroupa, Ľudmila Vodičková, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2

Anti-Inflammatory and Cancer-Preventive Potential of Chamomile (Matricaria chamomilla L.): A Comprehensive In Silico and In Vitro Study
Assia I. Drif, Rümeysa Yücer, Roxana Damiescu, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1484-1484
Open Access

Page 1 - Next Page

Scroll to top